Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Oxford Biomedica Plc (OXBL)

Add To Portfolio

323.50p

Change Today:

-0.073p
52 Week High: 444.50
52 Week Low: 235.50

Currency: UK Pounds
Volume: 3,113

OXBL Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

1 Day Chart

6 Month Chart

More Oxford Biomedica Plc charts

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

	Latest	F'cast
Div Yield	0.0%
Div Cover	n/a
Op Mrgn	-30.6%
ROCE	n/a

	Latest	F'cast
P/E	n/a
PEG	n/a
Pr/Revenue	n/a
Pr/Book	n/a

	Latest	F'cast
Revenue	43.8%
PBT	n/a
EPS	n/a
DPS	n/a

OXBL Fundamentals

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-20	87.73	(6.57)	(7.81)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-21	142.80	19.88	22.77p	53.9	n/a	n/a	n/a	0.0%
31-Dec-22	139.99	(45.98)	(41.29)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-23	89.54	(188.53)	(163.11)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-24	128.80	(47.26)	(41.75)p	n/a	n/a	n/a	n/a	0.0%

OXBL Company Announcements

No recent information was found.

OXBL ShareCast News

No recent information was found.

OXBL Top Newspaper Links

Need to know: Opec cuts forecast ... Tesco cuts ...	16-Aug-2008	Times
Need to know	10-May-2008	Times
DSG International may be losing its spark	12-Feb-2008	Telegraph